Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 38.15 CNY 3.05% Market Closed
Market Cap: 4.6B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao NovelBeam Technology Co Ltd
Capital Expenditures Peer Comparison

Comparables:
A
688617
J
002223
300760
J
300529
688271

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Capital Expenditures
-ÂĄ56m
CAGR 3-Years
7%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Capital Expenditures
-ÂĄ202m
CAGR 3-Years
-66%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Capital Expenditures
-ÂĄ101.6m
CAGR 3-Years
49%
CAGR 5-Years
28%
CAGR 10-Years
1%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Capital Expenditures
-ÂĄ2.5B
CAGR 3-Years
-23%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Capital Expenditures
-ÂĄ302.8m
CAGR 3-Years
17%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Capital Expenditures
-ÂĄ1.1B
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Qingdao NovelBeam Technology Co Ltd's Capital Expenditures?
Capital Expenditures
-56m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Capital Expenditures amounts to -56m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-10%

Over the last year, the Capital Expenditures growth was 45%. The average annual Capital Expenditures growth rates for Qingdao NovelBeam Technology Co Ltd have been 7% over the past three years , -10% over the past five years .

Back to Top